(Q38884628)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor-kappa B (RANK) Signaling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Elizabeth A Saria

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Marc F Hansen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

1 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular Physiology

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

2951-2960

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893522%20AND%20SRC:MED&resulttype=core&format=json

RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells.

6 March 2020

cites work

1 reference

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes

21 January 2018

1 reference

Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors

21 January 2018

1 reference

Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis

21 January 2018

1 reference

Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors.

21 January 2018

1 reference

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells.

21 January 2018

1 reference

Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase

21 January 2018

1 reference

Development and characterization of a conditionally immortalized human fetal osteoblastic cell line

21 January 2018

1 reference

Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling.

21 January 2018

1 reference

RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism.

21 January 2018

1 reference

In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.

21 January 2018

1 reference

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology

21 January 2018

1 reference

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

21 January 2018

1 reference

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands

21 January 2018

1 reference

U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells.

21 January 2018

1 reference

Involvement of integrin up-regulation in RANKL/RANK pathway of chondrosarcomas migration

21 January 2018

1 reference

RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer

21 January 2018

1 reference

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

Regulation of cancer cell migration and bone metastasis by RANKL.

21 January 2018

1 reference

Lysophosphatidic acid-induced ERK activation and chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF receptor transactivation

21 January 2018

1 reference

Akt1 in osteoblasts and osteoclasts controls bone remodeling

21 January 2018

1 reference

Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells

21 January 2018

1 reference

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis

21 January 2018

1 reference

21 January 2018

Emerging MEK inhibitors.

1 reference

Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells

21 January 2018

1 reference

Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas

21 January 2018

1 reference

Chemotaxis of human articular chondrocytes and mesenchymal stem cells

21 January 2018

1 reference

Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B.

21 January 2018

1 reference

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

21 January 2018

1 reference

IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts.

21 January 2018

1 reference

Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling

21 January 2018

1 reference

Cell migration: integrating signals from front to back

21 January 2018

1 reference

Acute mitochondrial inhibition by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK) 1/2 inhibitors regulates proliferation

21 January 2018

1 reference

The EGFR network in bone biology and pathology

21 January 2018

1 reference

p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades

21 January 2018

1 reference

Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells

21 January 2018

1 reference

Bone resorption by osteoclasts

21 January 2018

1 reference

Genetic regulation of osteoclast development and function

21 January 2018

1 reference

RANK-L and RANK: T cells, bone loss, and mammalian evolution

21 January 2018

1 reference

Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts

21 January 2018

1 reference

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

21 January 2018

1 reference

Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts

21 January 2018

1 reference

The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis

21 January 2018

1 reference

Off-target effects of MEK inhibitors

21 January 2018

1 reference

ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase

21 January 2018

1 reference